{"id":7521,"date":"2020-06-12T14:45:29","date_gmt":"2020-06-12T21:45:29","guid":{"rendered":"https:\/\/depts.washington.edu\/pandemicalliance\/?p=7521"},"modified":"2021-03-25T14:46:18","modified_gmt":"2021-03-25T21:46:18","slug":"seroprevalence-of-anti-sars-cov-2-igg-antibodies-in-geneva-switzerland-serocov-pop-a-population-based-study","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/12\/seroprevalence-of-anti-sars-cov-2-igg-antibodies-in-geneva-switzerland-serocov-pop-a-population-based-study\/","title":{"rendered":"Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Geneva, Switzerland (SEROCoV-POP): A Population-Based Study"},"content":{"rendered":"<ul>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"37\" data-aria-posinset=\"1\" data-aria-level=\"1\"><span data-contrast=\"auto\">*<\/span><span data-contrast=\"auto\">A population-based\u00a0<\/span><span data-contrast=\"auto\">household\u00a0<\/span><span data-contrast=\"auto\">serosurvey<\/span><span data-contrast=\"auto\">\u00a0<\/span><span data-contrast=\"auto\">conducted in Geneva, Switzerland<\/span><span data-contrast=\"auto\">\u00a0found that a<\/span><span data-contrast=\"auto\">ccounting for test validity (sensitivity and specificity) using Bayesian methods, seroprevalence increased over the first three weeks\u00a0<\/span><span data-contrast=\"auto\">of the repeated survey\u00a0<\/span><span data-contrast=\"auto\">(3.8% in week 1, 8.5% in week 2, and 10.9% in week 3).\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<li data-leveltext=\"\uf0b7\" data-font=\"Symbol\" data-listid=\"37\" data-aria-posinset=\"2\" data-aria-level=\"1\"><span data-contrast=\"auto\">Seropositivity was significantly lower among those 5-9 years old (<\/span><span data-contrast=\"auto\">RR<\/span><span data-contrast=\"auto\">=<\/span><span data-contrast=\"auto\">0.32, 95% CI 0.11-0.63) and those over 65 (<\/span><span data-contrast=\"auto\">RR<\/span><span data-contrast=\"auto\">=<\/span><span data-contrast=\"auto\">0.5, 95% CI 0.28-0.78) compared with those 20-49. The authors estimated 11.6 infections for every reported case.\u00a0<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><i><span data-contrast=\"none\">Stringhini\u00a0et al. (June 2020). Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Geneva, Switzerland (SEROCoV-POP): A Population-Based Study. The Lancet.\u00a0<\/span><\/i><a href=\"https:\/\/doi.org\/10.1016\/S0140-6736(20)31304-0\"><i><span data-contrast=\"none\">https:\/\/doi.org\/10.1016\/S0140-6736(20)31304-0<\/span><\/i><\/a><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"auto\">* This\u00a0<\/span><span data-contrast=\"auto\">study was first included in the\u00a0<\/span><span data-contrast=\"auto\">Lit Rep<\/span><span data-contrast=\"auto\">\u00a0as a pre-print on May 7, 2020. Findings are largely unchanged.<\/span><span data-ccp-props=\"{&quot;134233279&quot;:true,&quot;201341983&quot;:0,&quot;335559685&quot;:720,&quot;335559739&quot;:160,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>*A population-based\u00a0household\u00a0serosurvey\u00a0conducted in Geneva, Switzerland\u00a0found that accounting for test validity (sensitivity and specificity) using Bayesian methods, seroprevalence increased over the first three weeks\u00a0of the repeated survey\u00a0(3.8% in week 1, 8.5% in week 2, and 10.9% in week 3).\u00a0\u00a0 Seropositivity was significantly lower among those 5-9 years old (RR=0.32, 95% CI 0.11-0.63) and those over 65&#8230;<\/p>\n<div><a class=\"more\" href=\"https:\/\/depts.washington.edu\/pandemicalliance\/2020\/06\/12\/seroprevalence-of-anti-sars-cov-2-igg-antibodies-in-geneva-switzerland-serocov-pop-a-population-based-study\/\">Read more<\/a><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[6],"tags":[],"topic":[16],"class_list":["post-7521","post","type-post","status-publish","format-standard","hentry","category-article-summary","topic-public-health-policy-and-practice"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7521","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/comments?post=7521"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7521\/revisions"}],"predecessor-version":[{"id":7522,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/posts\/7521\/revisions\/7522"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/media?parent=7521"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/categories?post=7521"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/tags?post=7521"},{"taxonomy":"topic","embeddable":true,"href":"https:\/\/depts.washington.edu\/pandemicalliance\/wp-json\/wp\/v2\/topic?post=7521"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}